Patent directory · USPTO A61K / A61P
Patents matching “Aurigene Discovery Technologies Limited”
42 pharma patents match "Aurigene Discovery Technologies Limited" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 42 pharmaceutical patents matching "Aurigene Discovery Technologies Limited" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 11691987
Bicyclic heterocyclyl derivatives as IRAK4 inhibitors
granted -
US 11542275
Substituted imidazolidin-2-one derivatives as PRMT5 inhibitors
granted -
US 11512060
1,2,4-oxadiazole derivatives as immunomodulators
granted -
US 11497735
Conjoint therapies for immunomodulation
granted -
US 11497734
Dual inhibitors of TIM-3 and PD-1 pathways
granted -
US 11465976
1,2,4-oxadiazole and thiadiazole compounds as immunomodulators
granted -
US 11419875
Compounds and compositions for treating hematological disorders
granted -
US 11365205
Imidazolidin-2-one compounds as PRMT5 modulators
granted -
US 11311517
Combination of small molecule CD-47 inhibitors with other anti-cancer agents
granted -
US 11274123
1,2,4-oxadiazole compounds as inhibitors of CD47 signalling
granted -
US 11229636
Substituted tetrahydroquinolinone compounds as ROR gamma modulators
granted -
US 11186576
Pyrazolo[1,5-A][1,3,5]triazine and pyrazolo[1,5-A]pyrimidine derivatives as CDK inhibitors
granted -
US 11174232
Substituted heterocyclyl derivatives as CDK inhibitors
granted -
US 11147801
Methods of use for trisubstituted benzotriazole derivatives as dihydroorotate oxygenase inhibitors
granted -
US 10995100
Bicyclic heterocyclyl derivatives as IRAK4 inhibitors
granted -
US 10961205
1,2,4-oxadiazole derivatives as immunomodulators
granted -
US 10894786
Substituted pyrazole derivatives as selective CDK12/13 inhibitors
granted -
US 10781189
1,2,4-Oxadiazole and thiadiazole compounds as immunomodulators
granted -
US 10689347
Substituted heterocyclyl derivatives as CDK inhibitors
granted -
US 10640517
Bicyclic heterocyclyl derivatives as IRAK4 inhibitors
granted -
US 10590093
1,2,4-oxadiazole derivatives as immunomodulators
granted -
US 10173989
1,2,4-oxadiazole derivatives as immunomodulators
granted -
US 10160736
1,3,4-oxadiazole and 1,3,4-thiadiazole derivatives as immunomodulators
granted -
US 10160753
Indazole compounds as IRAK4 inhibitors
granted